Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting

BACKGROUND: Recent large clinical trials show lower rates of late cardiovascular events by extending clopidogrel >12 months after percutaneous coronary revascularization (PCI). However, concerns of increased bleeding have elicited support for limiting prolonged treatment to high-risk patients. OB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Coll Cardiol
Main Authors: Thukkani, Arun K., Agrawal, Kush, Prince, Lillian, Smoot, Kyle J., Dufour, Alyssa B., Cho, Kelly, Gagnon, David R., Sokolovskaya, Galina, Ly, Samantha, Temiyasathit, Sara, Faxon, David P., Gaziano, J. Michael, Kinlay, Scott
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578293/
https://ncbi.nlm.nih.gov/pubmed/26337986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2015.06.1339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados